high volume of these drugs used and suggestions that some The genotoxicity of atenolol, a β-blocker antihypertensive members of this chemical class may produce chronic toxicodrug, both in vitro and in vivo, was cytogenetically tested logical effects, the regulatory agencies have become concerned for its ability to induce sister chromatid exchange (SCE) over the possible long-term adverse effects of β-blockers and micronuclei (MN) in cultured peripheral lymphocytes. (Jackson and Fishbein, 1986) .
Also, fluorescence in situ hybridization (FISH) with a
In their review, Jackson and Fishbein (1986) reported the centromeric probe was performed to determine the origin toxicological data available on 18 β-blockers. Several of them of the induced MN. The in vivo study was carried out, on were reported to have some indication of carcinogenic or the one hand, on four patients under antihypertensive tumorigenic activity whereas the results were negative in all treatment with atenolol and, on the other hand, on four cases except for one when β-blockers were tested in one or matched control individuals taking an oral dose of atenolol.
more mutagenicity test systems (principally the Ames test and The in vitro study was performed on the control individuals the micronucleus test in CF1 outbred mice). However, apart by adding the drug to the culture medium at a final from this review, the published literature concerning genotoxic concentration similar to the levels found in plasma. When studies on antihypertensive drugs in general and β-blockers in a comparison was made, the frequency of SCE did not particular is poor. Only a few studies have been published in show significant differences in any case. A statistically the last few years (for example Aruna and Krishnamurthy, significant increase in the frequency of MN was detected 1986; Grisolia and Takahashi, 1991; Martelli et al., 1992 ; in patients but not in control individuals either in vitro or Tsutsui et al., 1994; Herzog and Leuschner, 1995;  Martelli in vivo. FISH analysis revealed statistically significant et al., 1995; Gasiorowski et al., 1997; Andreassi et al., 1999 ; differences between patients and control individuals with- Nesterova et al., 1999) , some of them with positive results. out the drug with respect to the frequency of centromeric Human populations exposed in vivo to possible genotoxic signals in MN. Taking all these observations together, our agents can be monitored using different chemical and biological data suggest that chronic exposure to atenolol resulted end-points. Pharmaceutical companies in Europe, the USA and mainly in the induction of chromosome loss, so an aneugenic Japan require tests for gene mutation in bacteria, chromosomal activity could be predicted. Different sensitivity to the aberrations in mammalian cells and in vivo mammalian cell compound was observed among control individuals. Nevertests to detect chromosomal damage (Purves et al., 1995) . theless, all of them responded to the presence of atenolol However, there are differences of opinion regarding the in the same way in both assays. Interindividual variability most appropriate tests to use in genotoxicity testing of was also reported. The intervariability seen in patients pharmaceuticals (Aaron et al., 1993; Purves et al., 1995) . suggested an adaptive response to the chemical after longCytogenetic end-points such as sister chromatid exchange term therapy.
(SCE) and micronucleus (MN) formation have potential use as indicators of chromosomal damage and have been used during recent decades in a lot of studies to evaluate the induction and persistence of cytogenetic alterations in Introduction individuals and populations with medical, occupational or Arterial hypertension is a health problem representing one of accidental exposure (Tucker et al., 1997) . the most frequent diagnoses in the population at large in terms SCE are events that involve breaks in both chromatids of a of prevalence and incidence. Several studies carried out during single chromosome, at coincident locations, with subsequent the last two decades in Spain have estimated that~20% of the interchange and repair (Latt et al., 1981) . SCE have been adult population suffer from arterial hypertension, of whom evaluated in numerous studies involving human exposure to only 50-60% are aware of it and 40-50% are treated with pharmaceuticals (Giri et al., 1996; Awara et al., 1998; Migliore et al., 1998; Vlastos et al., 1998; Lanza et al., 1999) . antihypertensive drugs. Antihypertensive drug consumption *To whom correspondence should be addressed. Tel: ϩ34 4 601 5409; Fax: ϩ34 4 464 8500; Email: ggbtesem@lg.ehu.es test with and without metabolic activation have shown that atenolol does not possess mutagenic potential (Fitzgerald, 1979) . Atenolol was also studied in the MN test in adult CF1 outbred mice and no significant, dose-dependent increase in the number of MN was observed (Okine et al., 1983) . The effects of atenolol in producing DNA damage in vitro and in vivo in liver nuclei of outbred Wistar rats were studied (Presta et al., 1983) but there was no evidence of DNA damage produced by atenolol. Finally, there was no teratogenic potential exhibited by atenolol in either rats or rabbits (Fitzgerald, 1979) .
We report here our data from a study of the genotoxic potential of atenolol, which was tested for its ability to induce SCE and MN in cultured human peripheral blood lymphocytes of treated patients and control individuals in vitro and in vivo. MN are acentric chromosome fragments or whole chromosomes that are left behind during mitotic cellular division and
The origin of MN was determined by FISH with a probe detecting all human centromeres. We are not aware of other appear in the cytoplasm of interphasic cells as small additional nuclei. There are several genotoxic studies on pharmaceutical studies done in lymphocytes of hypertensive patients under treatment with antihypertensive β-blocker drugs. compounds using this assay (Migliore et al., 1991 (Migliore et al., , 1998 (Migliore et al., , 1999 Erexson et al., 1995; Gutiérrez et al., 1997; Miele et al., 1998; Vlastos and Stephanou, 1998; Monsieurs et al., 1999 Tanzarella, 1988; Vanderkerken et al., 1989) . At present, respect to sex, age and smoking habit (in this present study all individuals fluorescence in situ hybridization (FISH) with centromerewere non-smokers). Patients (three male and one female) ranged in age from 39 to 79 years with an average age of 52.75 years. All of them received a specific DNA probes is a valuable approach of increasing dose of 50 mg atenolol/day (one tablet) by oral administration. The mean interest and it is being increasingly used in monitoring duration of treatment was 3.4 years (8 months-6 years). None of them were studies (Miller et al., 1994; Eastmond et al., 1995; Parry undergoing other medical treatments. They did not have a previous history of et Zijno et al., 1996; Ramírez et al., 1997; exposure to genotoxic compounds or recent X-ray examination. Each patient et al., Thierens et al., 1999) . Since the presence of a was given a code number (P1-P4) according to the sequence of blood collection. All patients gave informed consent to take part in this study.
hybridization signal in a MN is a direct measure of the Control individuals (three male and one female) had an average age of 52.5 presence of a centromere (Tusell et al., 1996; years. All of them were healthy individuals not undergoing any pharmaceutical 1998), this methodology allows detection of chromosome loss compound intake, X-ray exposure nor alcohol and/or drug consumption in the (Kirsch-Volders et al., 1996; Migliore et al., 1997; Ramírez recent past. Each control individual was given a code number (C1-C4) according to the sequence of arrival at the laboratory. Informed consent was et al. , 1997) .
obtained from control individuals to take part in the study.
To our knowledge, there are no published data using SCE
Blood collection and cell cultures
and/or MN assays in humans to assess chromosomal damage Several cultures were established depending on the group. For patients, venous of β-blockers. The treatment of hypertension is long and blood was taken from each subject and duplicate whole blood cultures were continuous (years) and, therefore, patients are exposed to set up. These cultures were numbered P1-P4. For control individuals, three prolonged contact with these drugs. So, it would be of interest different cultures were performed. On day T-1 (1 day prior to dosing), venous to evaluate any long-term genotoxic effects of antihypertensive blood was taken from each subject and duplicate whole blood cultures were drugs (β-blockers among them) using the different assays set up, numbered C1/T-1-C4/T-1 (controls/T-1). Another set of cultures was performed by adding the chemical compound to the culture medium at the available both in vitro and in vivo in humans. start of culture. Previously, atenolol, kindly provided by Dr Ortiz-Lastra, had
For this purpose, we chose the β-blocker atenolol because been dissolved in dimethyl sulphoxide to give a final concentration in the of its widespread use not only for the treatment of hyperculture medium similar to that found in patients after oral intake (these tension but for the treatment of angina pectoris, cardiac analyses were performed in the Department of Analytical Chemistry, University of the Basque Country, Spain). These cultures were numbered C1/mediumarrhythmia and heart attack. The chemical structure of atenolol C4/medium (controls/medium). On day T (day of dosing), each control
individual received a therapeutic oral dose of 50 mg atenolol (one tablet). On acetamide} is shown in Figure 1 . The dose levels are between day Tϩ1 (1 day after dosing), venous blood was taken from each individual 50 and 100 mg atenolol/day by oral administration. Activity and duplicate lymphocyte cultures were set up. These cultures were numbered starts 60 min after oral intake and lasts 24 h. Atenolol is C1/Tϩ1-C4/Tϩ1 (controls/Tϩ1).
This methodology was based on the study by Kirkland et al. (1992) .
rapidly absorbed from the gut and blood levels reach a peak
Cytogenetic tests
concentration in 2-3 h (Fitzgerald, 1979) . Due to its hydrophilic nature, metabolism of atenolol is minimal and almost the total Lymphocyte cultures were set up by adding 0.5 ml of heparinized whole blood to 4.5 ml of RPMI 1640 medium (Gibco), supplemented with 10% absorbed drug (85-100%) is cleared via excretion in the urine foetal bovine serum (Gibco), antibiotics (penicillin and streptomycin) (Gibco),
in an unaltered manner (Wadworth et al., 1991) .
glutamine (Gibco) and HEPES buffer solution (Gibco). Lymphocytes were
In their review, Jackson and Fishbein (1986) reported the stimulated with 4% phytohaemagglutinin (Gibco). Atenolol was added to toxicity data available on atenolol. In chronic studies with those cultures numbered C1/medium-C4/medium. For the SCE assay, the cultures were incubated at 37°C for 72 h in the dark C57B1/10J mice and Alderley Park Strain I rats, it was and 5-bromodeoxyuridine (Sigma) was added 24 h after the initiation of concluded that there was no evidence that atenolol had any culture at a final concentration of 12 µg/ml. One hour prior to harvesting, tumorigenic potential (Fitzgerald, 1979) . Studies including the 0.4 µg/ml of colcemid (Gibco) was added to arrest the cells at metaphase.
dominant lethal test, in vivo cytogenetics of Chinese hamster
For the MN assay, the cultures were incubated at 37°C for 72 h. Binucleated cells were accumulated by adding cytochalasin B (Cyt-B) (Sigma) at a final bone marrow and the Salmonella typhimurium back mutation concentration of 6 µg/ml (Surrallés et al., 1992) at 48 h following initiation of culture. At the end of the incubation time, the cells were collected Mean in controls/Tϩ1 9.67 Ϯ 0.27 2.24 Slide scoring For the SCE assay, a total of 50 well-spread metaphases of the second a P Ͻ 0.001, Student's t-test. division were examined for each individual and type of culture on coded slides in a blind study. Statistical analysis for SCE was performed using the was compared with those found in controls/medium (9.03) and t-test. One hundred metaphases were also scored to determine the proportion of cells that had undergone one, two and three or more divisions. The in controls/Tϩ1 (9.67), it could be observed that the SCE proliferative rate index (PRI) was evaluated according to the formula PRI ϭ values increased slightly when atenolol was present in the atenolol was tested in vivo. In spite of this tendency, individual C1 was the only one in which the SCE frequencies obtained Results in the three different cultures were statistically significant (P Ͻ 0.001 comparing both C1/T-1 with C1/medium and The effect of atenolol on the induction of SCE is summarized in Table I . In Table I the mean number of SCE per cell C1/T-1 with C1/Tϩ1). All these observations together seem to indicate that, despite the interindividual variability and (Ϯ SE) and the PRI values obtained after the different treatments with atenolol in each subject and in the total sample sensitivity, all individuals responded to the presence of the chemical in the same way. are reported.
The mean frequency of SCE in patients (8.08) was slightly The results of the MN study are shown in Table II . This table shows the percentage of BN cells, the distribution of increased with respect to controls/T-1 (7.94), but the differences were not statistically significant (P Ͼ 0.05). On the MN in the 1000 BN cells scored, the total number of MN, the total number of BNMN and the NDI values obtained after other hand, when the SCE frequency in controls/T-1 (7.94) the different treatments with atenolol in each subject and in to indicate an effect of the chemical in inducing the significantly higher frequencies of MN and BNMN in patients. The NDI measure, reflecting the average number of nuclei was tested in vitro, although they did not reach the significance level in this case, while individual C3 had the lowest MN and per cell, did not show significant differences when patients were compared with controls/T-1, with controls/medium and BNMN frequencies of all cultures. These observations suggest that all individuals respond to the presence of atenolol in the with controls/Tϩ1 (P Ͼ 0.05). In the same way, no statistical differences were found when controls/T-1 were compared same way. The application of FISH with a centromeric probe to with controls/medium and with controls/Tϩ1 (P Ͼ 0.05). Accordingly, atenolol does not seem to show cellular toxicity determine the nature of atenolol-induced MN gave the results reported in Table III . In Table III the total number and in vitro or in vivo.
Variability among individuals can be observed in both percentage of CN -and CN ϩ among the 50 MN scored for each subject and for the total sample are reported. Only groups. Among patients, individual P4 again presented the highest MN and BNMN frequencies. Among control indivipatients and controls/T-1 were analysed for the presence of centromeric signals. duals, the MN and BNMN frequencies in general increased when atenolol was added to the culture medium but these Among control individuals, approximately half of the observed MN were CN ϩ , whereas among patients, this values were the same as found in controls/T-1 when atenolol was tested in vivo. Individual C1 showed the greatest differpercentage increased to 70% of the total MN scored. When the percentage of CN ϩ MN in patients (70%) was compared ences in the frequencies of MN and BNMN when atenolol with the same percentage in controls/T-1 (48%), the differences Carrano and Natarajan, 1988; Tucker et al., 1997;  Migliore were statistically significant (P Ͻ 0.01). These results seem et al., 1998; Monsieurs et al., 1999) . The use of multiple endto suggest an ability of atenolol to induce chromosome points in the same population can provide valuable information loss in vivo.
relative to the sensitivity of each end-point as well as to the Slight variability among individuals was observed in both potential hazard for the population (Carrano and Natarajan, groups. Among patients, P1, the only female and the oldest 1988). individual, presented the highest percentage of CN ϩ , whereas
The SCE test provides a powerful tool to evaluate genetic the other patients' frequencies were similar. Among control damage deriving from exposure to genotoxic agents (Lambert individuals, all of them presented similar rates of CN -and et al., 1976; Morimoto et al., 1993; Tucker and Preston, 1996 ; CN ϩ MN. Tucker et al., 1997) and it assesses the impact of clastogens on chromosomes (Latt et al., 1981; Carrano and Natarajan, 1988; Morimoto et al., 1993; Wolff, 1998) .
Discussion
The MN test, after the improvement introduced by Fenech Unlike the results reported by Jackson and Fishbein (1986) in and Morley (1985) in using Cyt-B to arrest cytokinesis, has their review, the present study revealed a variety of cytogenetic been adopted by many laboratories world wide as a sensitive effects of atenolol in cultured human lymphocytes.
and reliable method for assessing chromosomal damage Recent studies point to important structural differences (Duffaud et al., 1997; Surrallés and Natarajan, 1997; Fenech, among different eukaryote organisms (yeast, rat, mouse and 1998) because of its ability to detect both chromosome breakage man) (Aardema et al., 1998) . Toxicological data from animal (clastogenicity) and loss (aneuploidy), two mechanisms experiments can only be used to a limited extent for human involved in genetic and carcinogenic risk (Heddle et al., 1991; risk assessment (Hagmar et al., 1998) because, as Aardema Marzin, 1997; Miller et al., 1998; van Delft et al. (1998) pointed out, 'to date, there is no information on et al., 1998) . This test combined with FISH with a centromeric the relevance of the data obtained in experimental animals probe is considered a useful screen to distinguish between for human beings and this is an area requiring further clastogenic and aneugenic agents by analysing the chromosome investigation'. Another critical factor that is often difficult to content of MN Ramírez et al., 1997 ; gauge is the likely exposure of humans to the drug. The Thierens et al., 1999) . disease entity and factors related to bioavailability (the fraction While SCE are indicative of an early biological effect that that will reach the circulation following oral exposure), may not be permanent and may not have further consequences, potency (plasma concentration required to produce the desired MN represent early but irreversible biological effects (van therapeutic effect) and biological persistence (half-life in the Delft et al., 1998) . body) often determine the exposure (Aaron et al., 1993) . On
Concerning the results obtained in our study, chronic the other hand, in vitro analysis alone is insufficient to identify exposure to atenolol did not seem to have clastogenic effects hazardous effects and in vivo analyses also have to be carried in vivo because no significant increases in the frequency of out (Vlastos et al., 1998) . One of the key factors leading to SCE were found in patients as compared with controls/T-1. discrepancies between the results in bacterial or cell culture Atenolol did not induce changes in the frequency of SCE in assays and the expected outcome in humans is differences in control individuals in any treatment. Although slight increases metabolism of the compound in vivo, since in vitro assays do could be observed in vitro (controls/medium) and in vivo not reflect the human body's absorption, distribution and (controls/Tϩ1) as compared with controls/T-1, these increases elimination of the compound (Aaron et al., 1993). were far from the level of significance. Thus, atenolol was In an attempt to clarify whether chronic exposure to the incapable of inducing SCE in peripheral lymphocytes after antihypertensive drug atenolol has any in vitro and/or in vivo long and short exposure to the chemical in vivo or after genotoxic effects on humans, this work reports the results of exposure in vitro. cytogenetic analyses of four patients following treatment with As regards the MN assay, the results indicate that chronic atenolol and four matched control individuals (controls/T-1, exposure to atenolol led to a statistically significant enhancecontrols/medium and controls/Tϩ1, according to the treatment ment of the two variables studied, total number of MN and followed; see Materials and methods), as determined by SCE total number of BNMN. These increases in the total frequency and MN assays in peripheral blood lymphocytes. FISH was of MN and BNMN were also statistically significant when also performed to determine the origin of the induced MN.
patients were compared with controls/medium and with Peripheral blood lymphocytes represent a good indicator of controls/Tϩ1, whereas there were no differences when comparexposure to genotoxic agents, carrying information on both ing the different treatments made among control individuals. doses and genotoxic effects (Morimoto et al., 1993; van Asten This seems to suggest that the effect of atenolol is observed et Anderson, 1999) . As they circulate throughout only in vivo and after continuous exposure. the body, this provides an estimate of average whole body
In this context, our results showing significant increases in exposure (Tucker and Preston, 1996) . In the case of in vivo MN and BNMN frequency in hypertensive patients after assays, two arguments are frequently presented for the decision treatment with atenolol indicate that the MN assay is sensitive to use human lymphocytes: on the one hand, cytogenetic tests enough to detect the chromosomal damage resulting from with established cell cultures tend to give more false positives treatment. This is in good agreement with previous reports than with human lymphocytes and, on the other hand, for the on drugs treatment (Erexson et al., 1995; Gutiérrez et al. , human situation human lymphocytes are more relevant than Miele et al., 1998; Migliore et al., 1998 ; Vlastos and non-human cell cultures (Müller et al., 1991) .
Stephanou, 1998). Also, the above-mentioned assays have been widely used In this assay, the spontaneous frequencies of MN were to evaluate the genotoxic potential of physical and chemical agents in vitro and in vivo (see for example Latt et al., 1981;  slightly lower than those reported by Surrallés et al. (1992) and Di Giorgio et al. (1994) , but they are in agreement with atenolol [8 months as compared with 3 (P3), 4 (P2) and 6 those reported by Parry et al. (1995) for human lymphocytes.
(P1) years]. The fact that this behaviour was repeated in all Taking the results obtained in both assays together, our data the assays led us to think of a non-casual event. suggest that chronic exposure to atenolol results mainly in the Dr Wolff's work on the induction of chromosomal aberrainduction of chromosome loss, suggesting a possible aneugenic tions (CA) in human lymphocytes has shown that low doses potential of the compound. This suggestion was confirmed of radiation trigger the induction of new proteins that are by FISH analysis using an α-satellite probe for all human involved in the repair of molecular lesions. Once induced, centromeres. The spontaneous frequency of MN containing these repair enzymes can be effective in cells for up to three centromeric signals is in good agreement with those reported cell cycles and cells 'adapted' with a low dose of radiation or previously (Cimini et al., 1996; Tusell et al., 1996; Migliore chemical show much less damage after a subsequent exposure et al., Vlastos and Stephanou, 1998) . The statistically to a high dose of radiation or even chemical mutagens than significant differences in CN ϩ MN between patients and observed in cells not pre-exposed (adapted) to the low doses. control individuals indicate more frequent involvement of This phenomenon has been termed an 'adaptive response' to aneuploidy (specifically chromosome loss) phenomena in the low doses. The adaptive response can also be induced in vivo origin of atenolol-induced MN in vivo. These results agree with low, or chronic, doses (Wolff, 1998) . So it seems that with those previously reported by the SCE assay. From our low and chronic doses of atenolol could induce mechanisms results we can deduce that atenolol after long-term treatment whereby cells became somewhat refractory to the induction in vivo induces MN that contain mainly lagging chromosomes of damage by subsequent exposure. Migliore et al. (1991) Grummt et al., 1993; Farmer et al., 1996) . known to be higher in females (Nowinski et al., 1990; The phenomenon of adaptive response has now led to a et Guttenbach et al., 1994; Stone and Sandberg, world wide explosion of research in this area to see if the 1995; Scarpato et al., 1996; Migliore et al., 1997) . Our data current risk estimated for the effects of mutagens are approagree with this.
priate (Wolff, 1998) . Our findings require further investigation Concerning cytotoxicity, measured as PRI in the SCE test in order to determine the health significance of this event. and NDI in the MN technique, atenolol did not seem to show
The present work is the first report on monitoring the cellular toxicity in vitro or in vivo in any group. For the MN genotoxic potential of the antihypertensive drug atenolol assay, both BN (%) and NDI were calculated, as seen in Table  following in vivo treatment in humans. Our results obtained III, but statistical calculations were only applied to NDI since, using different biological end-points are interesting since it is as Surrallés et al. (1994) reported, 'the NDI is a better shown that an aneugenic effect of the drug can be observed parameter for measuring toxicity, or cell cycle delay, than after long exposure to the chemical. Taking into consideration % BN'. that this drug is administered to a wide spectrum of patients The present study has revealed interindividual variation in and that the treatment is for prolonged periods, the results the frequency of all end-points studied. The variability observed obtained reiterate the need to both extend this type of study among individuals may be associated with different factors, and to make a careful evaluation of the cost-benefit ratio of one being a particular individual's responsiveness to drugs, but apparently not with differences in experimental protocols this long-term treatment, as suggested by Bigatti et al. (1998) nor with age, sex and/or smoking habit.
for psychopharmacological treatment. In our work and among control individuals, C1 showed the An important point to address is the Basque origin of all highest differences in the frequency of all variables studied the individuals analysed in this study. The Basques constitute when atenolol was tested in vitro and in vivo. The increases an ancient population now living in the west of the Pyrenees observed were highly significant, suggesting the high sensitivity Mountains. Their origin is not exactly known. They speak an of this individual to the compound. Thus, it can be said that ancient language with very distinct characteristics different under these experimental conditions, for each control individual from the surrounding populations. Many studies, using different there was a different susceptibility to the chemical. This traits, have shown peculiarities in Basques as compared with differential response to atenolol could be attributed to differother populations (Arrieta et al., 1992 (Arrieta et al., , 1995  Cavalli-Sforza ences in genetic background among individuals that could and Piazza, 1993). Since there are no previous studies about influence metabolism of the compound, repair of DNA the incidence of chromosomal changes in Basque populations, damage and also the percentage of cells that respond to the a possible influence of a genetic component in the results chemical. Different individual sensitivity is not surprising and observed could not be ruled out. significant interindividual variations have been reported in the Although further investigations are needed as regards the frequencies of SCE and MN following exposure to a large influence of the Basque origin on the aneugenic potential and number of agents (Migliore et al., 1991; Grummt et al., 1993;  adaptive response observed, these preliminary results should Duffaud et al., 1997; Vlastos and Stephanou, 1998 ; Vlastos be borne in mind in future studies. et al., 1998) . Despite this different sensitivity to the chemical, all control individuals responded to the presence of atenolol in the same way in both assays.
